Also known as: PTH 1-34
Teriparatide is a synthetic peptide that represents a fragment of parathyroid hormone (PTH), specifically the first 34 amino acids of the full-length hormone. Classified under anabolic and myostatin peptides, Teriparatide is primarily utilized for its bone-anabolic properties, making it significant in the field of bone health and metabolism.
This peptide is designed to stimulate bone formation and is often researched for its potential in treating osteoporosis and other conditions associated with low bone density. By mimicking the action of natural PTH, Teriparatide plays a crucial role in regulating calcium and phosphate metabolism in the body.
Teriparatide functions by binding to the PTH receptors on osteoblasts, the cells responsible for bone formation. This interaction promotes the proliferation and activity of osteoblasts, leading to increased bone mineral density and overall bone strength.
The peptide enhances the differentiation of mesenchymal stem cells into osteoblasts while inhibiting osteoclast activity, which is responsible for bone resorption. This dual action results in a net gain in bone mass, making Teriparatide a valuable tool in bone health research.
Teriparatide is a key peptide in the realm of anabolic and myostatin peptides, primarily recognized for its ability to enhance bone formation and density. Its mechanisms of action and observed effects make it a significant subject of research in bone health and related therapeutic applications.
Last updated: Feb 25, 2026